SPDR Advertisement SureTrader SureTrader SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Organovo Holdings, Inc. (ONVO)

Add ONVO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator dshade
Search This Board:
Last Post: 7/3/2015 12:40:05 PM - Followers: 298 - Board type: Free - Posts Today: 0

     Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.
The company's NovoGen three-dimensional bioprinting technology is a platform that works across all tissue and cell types.
Organovo's NovoGen MMX Bioprinter was selected as one of the "Best Inventions of 2010" by TIME Magazine.
Organovo is helping pharmaceutical partners develop human biological disease models in three dimensions that enable therapeutic drug discovery and development.
Organovo's bioprinting technology can also be developed to create surgical tissues direct therapy.
Organovo leads the way in solving complex medical research problems and building the future of medicine.


ONVO Security Details Share Structure

Shares Outstanding 77,816,787 a/o Mar 16, 2014
Float 50,000,000 a/0 May24,2014
Authorized Shares 150,000,000 a/o May24, 2014

IR and Media Contacts:
Investor Relations Contact: ir@organovo.com
Media Contact: media@organovo.com

Mailing Address:
Organovo, Inc.
6275 Nancy Ridge Drive, Suite 110
San Diego, CA 92121
Phone: 1-858-550-9994

For all the latest company information, details, news, please visit http://www.organovo.com

Organovo's Scientific Founder and Chief Scientific Officer, Dr. Gabor Forgacs
is the Executive and Scientific Director of the Shipley Center for Innovation at Clarkson University and the George H. Vineyard Professor of Biological Physics at the University of Missouri.
He developed Organovo's breakthrough organ printing technology while leading a team of top regenerative medicine scientists from multiple universities, with the backing of a $5MM National Science Foundation Grant.
Professor Forgacs is the author of more than 150 peer reviewed journal articles and the textbook Biological Physics of the Developing Embryo, (with Stuart Newman), published by Cambridge University Press.
He holds a PhD in theoretical physics from the Roland Eotvos University, Budapest Hungary. He moved to the United States in the 1980's from the Institute of Physics of the French Atomic Energy Agency in Saclay to accept a professorship at Clarkson University. 
University of Missouri researcher doing groundbreaking work in regenerative medicine. Here is a video:


Organovo strives to advance regenerative medicine to new heights, by enabling bioprinting tissues and 3-D cellular constructs that were not possible before.
The novel and flexible capabilities of the bioprinting technology allow researchers to generate data faster and more efficiently, thus leading to cutting edge scientific findings, publications, and grants.

Organovo's 3-D NovoGen bioprinting technology allows for the placement of cells in any pattern desired.
First, small building blocks of any shape are created from the desired cell type.
Second, these pre-formed cell aggregates are loaded into a print cartridge that is then attached to the bio-printer.
The bioprinter deposits the cell aggregates one layer at a time, creating multiple stacked 2-D patterns.
A non-invasive gel is placed next to the cell aggregates to hold the desired 3-D shape as each layer is placed in 2-D.

After printing, the cell aggregates retain enough cellular mobility for them to flow into one another, creating a fused tissue construct.
The principles of developmental biology, including cellular self-assembly, allow the final construct to mature into the desired shape and properties.


World class support for NovoGen MMX

The NovoGen MMX Bioprinter™ is supported by our scientific and engineering team.
Every customer receives bioprinter training and access to Organovo's scaffold-free proprietary bioprinting process, which includes cell preparation to tissue maturation.
Additional consultation and application support are available upon request. Organovo's success comes from enabling our customers' success.  


NovoGen MMX Bioprinter

    The NovoGen MMX Bioprinter™ is a novel hardware and software platform at the forefront of bioprinting research and development. The NovoGen MMX™ was developed to meet challenges in biological research.
The platform takes primary or other human cells and shapes them into 3D tissue, with tremendous cellular viability and biology that is superior to even an animal model.
The platform is being used by Organovo's Pharma partners today to enable cutting edge research into drug discovery.

By allowing creation of three dimensional biological structures, Organovo creates functional human tissue that is superior to current disease models.
By enabling printing of tissue in a laboratory environment, investigations on the constructs can be integrated into your current analysis methods.

https://www.youtube.com/watch?v=1O3c3pUg0L8 (at 28 sec into the video is a full frontal view of the ONVO NovaGen MMX Bioprinter)

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ONVO News: Current Report Filing (8-k) 06/25/2015 08:06:34 AM
ONVO News: Organovo Holdings, Inc. To Present at Cantor Fitzgerald Inaugural Healthcare Conference 06/23/2015 04:05:00 PM
ONVO News: Current Report Filing (8-k) 06/18/2015 04:44:27 PM
ONVO News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 06/18/2015 04:41:32 PM
ONVO News: Organovo Holdings, Inc. Prices $40 Million Public Offering of Common Stock 06/18/2015 08:56:00 AM
#6071  Sticky Note ONVO Kidney news & Profile videos dshade 05/24/14 12:15:04 PM
#8390   $ONVO is about to be money printing time bfsingle 07/03/15 12:40:05 PM
#8389   Organovo Holdings, Inc. ( ONVO) , a three-dimensional RandolRocketman 07/02/15 07:27:11 PM
#8388   % Change in Institutional Shares Held up 13.43% paulscary 07/02/15 11:29:14 AM
#8387   stock bouncing at 3.6 right at the top bfsingle 07/02/15 10:05:48 AM
#8386   Ditto a Manager of Manufacturing. That implies nsomniyak 07/01/15 08:35:27 PM
#8385   Its always encouraging to see lab techs getting RandolRocketman 07/01/15 03:44:11 PM
#8384   More job postings from Organovo yesterday. paulscary 07/01/15 03:31:12 PM
#8383   Sr Scientist - Applied Research Skin Transformation paulscary 06/30/15 05:35:43 PM
#8382   Scientist I - Biolab R&I_L'Oreal - New Jersey paulscary 06/30/15 04:35:24 PM
#8381   Not sure what the board has to do RandolRocketman 06/30/15 03:15:31 PM
#8380   I want to shake my head at those RallyTheMarket 06/30/15 03:11:19 PM
#8379   Dilution doesn't matter. Short positions don't matter. Organovo RandolRocketman 06/30/15 03:03:26 PM
#8378   No support for this stock. Fell below $3.50 RallyTheMarket 06/30/15 02:06:37 PM
#8376   ? 3.75 - 3.88 Please explain lower ddbl_our_buck 06/30/15 08:55:58 AM
#8375   Keeps heading lower and lower and lower and lower Sand Piper 06/30/15 07:50:11 AM
#8374   Yes agreed. Thanks for that.. ddbl_our_buck 06/30/15 07:37:05 AM
#8373   Those 2 upgrades are encouraging at least. :-) rayank 06/30/15 05:34:08 AM
#8372   Agreed. Offering was actually $4.25. squashjohn 06/29/15 06:01:58 PM
#8371   Nice to see you back Gary. :-) rayank 06/29/15 04:38:02 PM
#8370   Buying back ONVO here for 3 reasons: 3DPrintInvestor 06/29/15 01:44:36 PM
#8369   Organovo Explains Why They’ve Raised an Additional $40M rookiecrd1 06/29/15 12:21:54 PM
#8368   COVERAGE INITIATED: Organovo (ONVO) initiated by Jefferies. Initial RandolRocketman 06/29/15 10:10:17 AM
#8367   death spirals are devastating to LT shareholder This chart Sand Piper 06/29/15 08:39:06 AM
#8366   Truly meaningless in the short term as well.His winnail 06/28/15 10:37:06 PM
#8365   Thanks! Truly meaningless to the longer term play. dadx4 06/28/15 12:53:39 PM
#8362   Abandon this sinking ship then Sand Piper. That's rayank 06/28/15 08:53:44 AM
#8361   Ship is sinking long term theres a whole Sand Piper 06/28/15 07:15:45 AM
#8360   Investors are pissed, but after reading their FAQ Yeti 06/27/15 08:41:23 AM
#8359   Death Spiral activates Chart was fhe first RED FLAG Hsppy Trading Sand Piper 06/27/15 08:13:23 AM
#8358   Tight stop got hit yesterday. Will re-enter at dadx4 06/26/15 11:41:27 AM
#8357   No volume as soon as people realize they Sand Piper 06/26/15 08:59:01 AM
#8356   Im buying today, ave down ... Im in sboy777 06/25/15 03:47:39 PM
#8355   $4.00 support. See chart attached. Please show me rayank 06/25/15 09:25:19 AM
#8354   Thanks. Not here for a quick flip. GL! dadx4 06/25/15 09:12:38 AM
#8353   Liquidity trap here chart says going down bigtime Sand Piper 06/25/15 09:10:29 AM
#8352   Chart looks like its heading straight down now Sand Piper 06/24/15 07:24:04 AM
#8351   Not a lot to talk about. I think bettyfordallstar 06/23/15 06:24:05 PM
#8350   ONVO might use the new capital to develop mantisforce 06/23/15 06:13:56 PM
#8349   Bought today. ONVO dadx4 06/23/15 06:06:23 PM
#8348   Shares Outstanding 90,962,000 RandolRocketman 06/23/15 09:57:14 AM
#8347   Sure is a quiet board here with the Spudskie 06/22/15 08:51:21 PM
#8346   I would say the smart Shorts will take CommonCents4Dollars 06/19/15 02:38:26 PM
#8345   It will not go under 4,25 imo. And declaes 06/19/15 01:28:46 PM
#8344   Well, well, here we are again. Last time wasdeafonce 06/19/15 01:26:21 PM
#8343   Unfortunatly i think we will have better ops. bettyfordallstar 06/19/15 03:38:50 AM
#8342   This is a big offering at a lower nsomniyak 06/19/15 12:29:47 AM
#8341   It would be nice to have a pr bettyfordallstar 06/18/15 11:15:48 PM
#8340   As long as they have a blackout period bettyfordallstar 06/18/15 11:13:11 PM
#8339   I can accept the dilution but not the Alvie 06/18/15 10:12:50 PM
#8338   There is a reason they are doing this. bettyfordallstar 06/18/15 09:51:13 PM